Details for Patent: 9,402,957
✉ Email this page to a colleague
Summary for Patent: 9,402,957
| Title: | Automatic injection device with delay mechanism including dual functioning biasing member |
| Abstract: | An automatic injection apparatus including a delay mechanism for properly delivering medication prior to the needled syringe of the apparatus being retracted. In one form, the delay mechanism includes a shuttle for the syringe, a follower, a locking member, a damping compound between the follower and a supporting surface to dampen rotation of the follower relative to the shuttle, and a dual functioning biasing member acting between the shuttle and the follower. When the locking member moves to a release position during an injection, the dual functioning biasing member first provides a torsional force to force the follower to rotate relative to the shuttle from a latching position to an unlatching position, and then the dual functioning biasing member provides an axial force to force the shuttle axially relative to the follower to move the shuttle for retracting the syringe needle into the housing of the apparatus after injection. |
| Inventor(s): | Adams; Matthew Robert (Mountain View, CA), Fourt; Jesse Arnold (Menlo Park, CA), Kaplan; Jonathan I. (Palo Alto, CA), Silberschatz; Paul Joseph (San Francisco, CA), Yurchenco; James R. (Palo Alto, CA) |
| Assignee: | Eli Lilly and Company (Indianapolis, IN) |
| Application Number: | 14/262,080 |
|
Patent Claim Types: see list of patent claims | Device; |
Recent additions to Drugs Protected by US Patent 9,402,957
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist Req. | Patent Expiration | Usecode | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Type | >RLD | >Patent No. | >Product | >Substance | >Delist Req. | >Patent Expiration | >Usecode | >Patented / Exclusive Use |
Drugs Protected by US Patent 9,402,957
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,402,957
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2011221472 | ⤷ Try a Trial | |||
| Australia | 2013260666 | ⤷ Try a Trial | |||
| Brazil | 112012022033 | ⤷ Try a Trial | |||
| Brazil | 122019022221 | ⤷ Try a Trial | |||
| Canada | 2791880 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
